LOXL2

LOXL2 분자 정보

영어 이름Lysyl oxidase homolog 2시판 약물 수0
임상 약물 수1표적 별명EC:1.4.3.13,EC 1.4.3,Lysyl oxidase-like protein 2,Lysyl oxidase homolog 2,LOXL2,Lysyl Oxidase Like 2,Lysyl Oxidase-Related Protein WS9-14,Lysyl Oxidase-Related Protein 2,Lysyl Oxidase-Like 2 Delta E13,Lysyl Oxidase-Like 2 Protein,Lysyl Oxidase Related 2,Lysyl Oxidase-Like 2,EC 1.4.3.13,WS9-14,LOR2,LOR
최고 연구 개발 단계Phase 2 Clinical
영어 이름Lysyl oxidase homolog 2
표적 별명EC:1.4.3.13,EC 1.4.3,Lysyl oxidase-like protein 2,Lysyl oxidase homolog 2,LOXL2,Lysyl Oxidase Like 2,Lysyl Oxidase-Related Protein WS9-14,Lysyl Oxidase-Related Protein 2,Lysyl Oxidase-Like 2 Delta E13,Lysyl Oxidase-Like 2 Protein,Lysyl Oxidase Related 2,Lysyl Oxidase-Like 2,EC 1.4.3.13,WS9-14,LOR2,LOR
시판 약물 수0
임상 약물 수1
최고 연구 개발 단계Phase 2 Clinical

LOXL2 제품 목록

  • 속성

    Protein (2)

  • 제품 라이브러리

    온라인 (2)

  • Human (2)

  • 태그

    His Tag & Avi Tag (1)His Tag (1)

  • 마커

    Biotin-labeled (1)Unconjugated (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
Human
HEK293
Human LOXL2 Protein, His Tag (active enzyme)
Human
HEK293
Biotinylated Human LOXL2 Protein, His,Avitag™ (active enzyme)
총 수량2
  • 1

LOXL2분자 배경

Lysyl oxidase homolog 2 is also known as LOXL2, Lysyl oxidase-like protein 2, which is expressed in many tissues, highest expression in reproductive tissues, placenta, uterus and prostate, Up-regulated in a number of cancers cells and tissues. LOXL2 mediates the post-translational oxidative deamination of lysine residues on target proteins leading to the formation of deaminated lysine (allysine). When secreted in extracellular matrix, promotes cross-linking of extracellular matrix proteins by mediating oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin. LOXL2 acts as a regulator of sprouting angiogenesis, probably via collagen IV scaffolding. When nuclear, acts as a transcription corepressor and specifically mediates deamination of trimethylated 'Lys-4' of histone H3 (H3K4me3), a specific tag for epigenetic transcriptional activation. LOXL2 acts as a regulator of chondrocyte differentiation, probably by regulating expression of factors that control chondrocyte differentiation.

LOXL2분자 별명

Lysyl oxidase homolog 2,LOXL2

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
GB-2064PAT-1251; GB-2064Phase 2 ClinicalPharmakea IncPolycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호